MORGAN STANLEY PLC/CALL/STRYKER CORP./425/0.1/21.03.25 Share Price

Warrant

DE000MG0YGZ1

Market Closed - Börse Stuttgart 19:50:53 31/05/2024 BST
0.59 EUR -6.35% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./425/0.1/21.03.25
Current month-27.16%
1 month-27.16%
Date Price Change
31/05/24 0.59 -6.35%
30/05/24 0.63 +3.28%
29/05/24 0.61 +12.96%
28/05/24 0.54 +1.89%
27/05/24 0.53 -1.85%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 07:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MG0YGZ
ISINDE000MG0YGZ1
Date issued 27/03/2024
Strike 425 $
Maturity 21/03/2025 (293 Days)
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.44
Lowest since issue 0.41
Spread 0.04
Spread %6.06%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus